Related Experiment Video
Updated: May 30, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
[Hypertricglyceridemia: prognostic impact and treatment options]
1Klinik für Innere Medizin III, Kardiologie, Angiologie und internistische Intensivmedizin, Universitätsklinikum des Saarlandes. florian.custodis@uks.eu
Insights
High triglyceride levels increase cardiovascular disease risk. Management involves lifestyle changes and, if needed, medications like fibrates and omega-3 fatty acids to lower triglycerides and vascular risk.
Area of Science:
- Cardiology
- Metabolic Disorders
Background:
- Elevated triglycerides are linked to atherosclerotic disease and vascular risk factors like obesity and hypertension.
- Assessing individual cardiovascular risk requires considering lipid profiles, comorbidities, and family history.
Observation:
- Hypertriglyceridemia management aims to reduce cardiovascular risk and prevent complications such as chylomicronemia syndrome.
- Lifestyle modifications including diet, exercise, weight loss, and smoking cessation are foundational treatments.
Findings:
- Pharmacotherapy with nicotinic acid, fibrates, or omega-3 fatty acid ethyl esters is indicated when lifestyle changes are insufficient.
- Optimizing non-HDL-cholesterol with statins is crucial for further vascular risk reduction.
Implications:
- Effective management of hypertriglyceridemia is vital for preventing cardiovascular events.
- A multi-faceted approach combining lifestyle and pharmacotherapy is essential for comprehensive cardiovascular risk reduction.
Abstract:
Elevated Triglyceride levels are associated with increased risk for atherosclerotic disease and additional vascular risk factors such as obesity, hypertension and impaired glucose tolerance. To estimate the individual cardiovascular risk of a patient with elevated triglycerides LDL- and HDL-cholesterol levels, concomitant diseases, composition of triglyceride rich lipoproteins and a family history for premature coronary heart disease are important. Primary goals for the management of hypertriglyceridemia are a reduction of cardiovascular risk and prevention of triglyceride associated complications such as the chylomicronemia syndrome. The basis of treatment are lifestyle changes: dietary intervention, alcohol avoidance, regular physical activity, weight loss and smoking cessation to modify risk factors. If triglyceride levels can not be sufficiently reduced by lifestyle intervention pharmacotherapy (nicotinic acid, fibrates and omega-3-acid ethyl esters) is indicated. Beyond reduction of triglyceride levels optimization of non-HDL-cholesterol by statin treatment is warranted to reduce vascular risk.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Acute Pancreatitis II: Clinical Manifestations and Management
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Angina IV: Management